- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 26.91M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $301.5M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $292.2M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $19.4M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $18.8M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $113.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $104M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $461.1M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $441.7M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $161.8M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $159.9M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $458.9M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $438.4M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 28.6M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $4.4M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $6M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$80.3M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$75.9M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$6.4M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$2.1M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $62.3M |